KW-6500

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for KW-6500, covering 2017-03-03 to 2020-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy [Phase 2]

See pricing